Chemomab Therapeutics’ Touts Positive Data From Experimental Drug For Chronic Liver Disease

All NewsMarch 27, 2025

Chemomab’s OLE study of nebokitug in PSC patients confirmed safety and showed improvements in liver stiffness, fibrosis biomarkers, and cholestasis markers.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Chemomab Therapeutics’ Touts Positive Data From Experimental Drug For Chronic Liver Disease

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Walmart’s $104 farmhouse shoe cabinet has 5 adjustable shelves and can hold 24 pairs of shoes

James Talarico’s historic Texas Senate victory deals blow to Elon Musk

US midterms 2026: Who would’ve thought that a war would be a bad idea?

Ethereum dev targets 2028 for quantum resistance, a year early

Walmart has a $75 2-in-1 laptop and tablet that comes with a wireless keyboard, mouse, and stylus